HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ransford O Kumi Selected Research

CRTH2 antagonist CT-133

3/2020Lipid-Embedded Molecular Dynamics Simulation Model for Exploring the Reverse Prostaglandin D2 Agonism of CT-133 towards CRTH2 in the Treatment of Type-2 Inflammation Dependent Diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ransford O Kumi Research Topics

Disease

1Acute Lung Injury
03/2020
1Hypersensitivity (Allergy)
03/2020
1Inflammation (Inflammations)
03/2020
1Allergic Rhinitis
01/2019
1Alzheimer Disease (Alzheimer's Disease)
01/2019
1Asthma (Bronchial Asthma)
01/2019

Drug/Important Bio-Agent (IBA)

1SmokeIBA
03/2020
1Prostaglandin D2IBA
03/2020
1ramatrobanIBA
03/2020
1Formyl Peptide Receptors (Formyl Peptide Receptor)IBA
03/2020
1CRTH2 antagonist CT-133IBA
03/2020
1LipidsIBA
03/2020
1CAY 10471IBA
01/2019
1CaspasesIBA
01/2019
1fevipiprantIBA
01/2019

Therapy/Procedure

1Ligation
03/2020